Presser-Belkin Liza MD is categorized under Doctors in Santa Barbara, CA and active since 2008.
Presser-Belkin Liza MD was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Liza Presser-Belkin at the company’s single location by writing to 5333 Hollister Avenue # 135, Santa Barbara, California CA 93111 or by phoning (805) 569-3377. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Presser-Belkin Liza MD |
| Contact Person: | Liza Presser-Belkin |
| Address: | 5333 Hollister Avenue # 135, Santa Barbara, California 93111 |
| Phone Number: | (805) 569-3377 |
| Website Address: | drpresserbelkin.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Presser-Belkin Liza MD was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Liza Presser-Belkin for inquiries that concern Presser-Belkin Liza MD by calling the company number (805) 569-3377, as your correspondence is most welcome. Additionally, the physical location of the single location of Presser-Belkin Liza MD can be found at the coordinates 34.43491,-119.81014 as well as the street address 5333 Hollister Avenue # 135 in Santa Barbara, California 93111.
For its online presence, you may visit Presser-Belkin Liza MD’s website at drpresserbelkin.com and engage with its social media outlets through on Twitter and on Facebook.